11 min listen
ACC CardiaCast: Risk-Benefit Analysis and Dosing
FromACC CardiaCast
ratings:
Length:
10 minutes
Released:
Aug 6, 2018
Format:
Podcast episode
Description
This podcast discusses the risks and benefits of starting new diabetes therapies on a patient with type 2 diabetes. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
Released:
Aug 6, 2018
Format:
Podcast episode
Titles in the series (96)
ACC CardiaCast: PAD: You Can't Treat What You Don't Know is There: In this podcast, Naomi Hamburg discusses risk assessment and peripheral arterial disease (PAD) therapies in patients. Identification of PAD, exercise interventions, and pharmacotherapy are examined. This is a rebroadcast from the clinical focus... by ACC CardiaCast